Scynexis (SCYX) Non-Current Deffered Revenue (2013 - 2025)
Scynexis (SCYX) reported Non-Current Deffered Revenue of $807000.0 for Q3 2025, down 37.92% on a YoY basis from $1.3 million in Q3 2024, and up 61.4% quarter-over-quarter from $500000.0 in Q2 2025.
Scynexis (SCYX) Non-Current Deffered Revenue (2013 - 2025) Analysis & Trends
Scynexis has reported Non-Current Deffered Revenue for 9 years, with the latest figure at $807000.0 in Q3 2025.
- For the quarter ending Q3 2025, Non-Current Deffered Revenue fell 37.92% year-over-year to $807000.0; the trailing twelve-month figure through Sep 2025 stood at $807000.0 (down 37.92% YoY), and the FY2024 full-year result was $1.3 million, down 52.55% from the prior year.
- Non-Current Deffered Revenue for Q3 2025 stood at $807000.0, up from $500000.0 in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $2.7 million in Q4 2023, with the low at $500000.0 in Q2 2025.
- Historically, Non-Current Deffered Revenue has averaged $1.5 million across 3 years, with a median of $1.3 million in 2024.
- Annual changes were most pronounced in 2024 — Non-Current Deffered Revenue soared 59.39% — and 2025, when it slumped 72.48%.
- Scynexis' Non-Current Deffered Revenue stood at $2.7 million in 2023, then sank by 52.55% to $1.3 million in 2024, then tumbled by 37.64% to $807000.0 in 2025.
- The last three Non-Current Deffered Revenue figures came in at $807000.0 (Q3 2025), $500000.0 (Q2 2025), and $1.3 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | - |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | - |
| 10 | Scynexis | 221.66 Mn | 162.40 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 807,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 1.30 Mn |
| Dec 31, 2024 | 1.29 Mn |
| Sep 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.82 Mn |
| Mar 31, 2024 | 2.11 Mn |
| Dec 31, 2023 | 2.73 Mn |
| Sep 30, 2023 | 1.65 Mn |
| Jun 30, 2023 | 1.14 Mn |
| Mar 31, 2018 | 57,000.00 |
| Dec 31, 2017 | 121,000.00 |
| Jun 30, 2017 | 249,000.00 |
| Mar 31, 2017 | 314,000.00 |
| Dec 31, 2016 | 378,000.00 |
| Sep 30, 2016 | 25,000.00 |
| Jun 30, 2016 | 25,000.00 |
| Mar 31, 2016 | 571,000.00 |
| Dec 31, 2015 | 25,000.00 |
| Sep 30, 2015 | 699,000.00 |